<DOC>
	<DOCNO>NCT01382732</DOCNO>
	<brief_summary>Postpartum hemorrhage important cause maternal morbidity mortality . In patient severe preeclampsia increase risk postpartum hemorrhage hemodynamic change associate pathology make management kind bleed particularly troublesome . There many pharmacological option , oxytocin first line treatment . However evidence safety efficacy carbetocin , oxytocin agonist . The investigator aim compare oxytocin carbetocin routine prevention postpartum hemorrhage patient severe preeclampsia .</brief_summary>
	<brief_title>Carbetocin vs. Oxytocin Prevention Postpartum Bleeding Patients With Severe Preeclampsia</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Pregnant woman 28 week term Severe preeclampsia Twin pregnancy Coagulation disorder HELLP Syndrome Eclampsia</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Pre-eclampsia</keyword>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Carbetocin</keyword>
	<keyword>Oxytocin</keyword>
</DOC>